Israeli medical device company Insightec is in advanced talks to merge with a SPAC at a valuation of $2 billion, Globes reports, citing to sources familiar with the matter. Insightec has developed a device for minimally invasive surgery based on ultrasound.
Insightec CEO Maurice Ferre has already been involved in one SPAC merger of an Israeli medical company when robotic surgery company Memic agreed in August to merge with MedTech Acquisition at a valuation of $1 billion. In the past, Ferre has said that he could see Insightec agreeing to an exit worth tens of billions of dollars. Read more.
